Back to today’s briefing

Story perspectives

Revolutionary Trial Tests Deep Brain Stimulation for Depression

5/2/2025

37 7

Summary

Story summary

The Icahn School of Medicine at Mount Sinai has launched the groundbreaking TRANSCEND trial, the first in the U.S. to investigate deep brain stimulation (DBS) for treatment-resistant depression. Dr. Brian H. Kopell believes that if successful, DBS could revolutionize psychiatry, diminish stigma, and pave the way for better insurance coverage for mental health care.

1 of 1

Story summary

The Icahn School of Medicine at Mount Sinai has launched the groundbreaking TRANSCEND trial, the first in the U.S. to investigate deep brain stimulation (DBS) for treatment-resistant depression. Dr. Brian H. Kopell believes that if successful, DBS could revolutionize psychiatry, diminish stigma, and pave the way for better insurance coverage for mental health care.